Viewing nowRosutan 20 Milligrams (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

MFDS item code 201503865 · Approved 2015.06.12 · Insurance code 653403280
Improvement of dyslipidemia; inhibition of atherosclerosis progression; prevention of cardiovascular disease
This medicine is used as an adjunct to diet in patients with primary hypercholesterolemia and mixed dyslipidemia who are not well controlled by diet and exercise. It is particularly used as an adjunct to other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. This drug lowers total cholesterol and LDL cholesterol levels and has the effect of delaying the progression of atherosclerosis. It can be safely used in pediatric patients aged 10 to 17 years who meet specific criteria for familial hypercholesterolemia. It is also recommended as an adjunct to diet in patients with primary dysbetalipoproteinemia. Finally, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in patients at higher risk for cardiovascular diseases. Therefore, this medicine improves hyperlipidemia and the risk of associated cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication, and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams once daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Under 10 years: Safety and efficacy have not been established.
This drug should not be used in certain patients. For example, individuals allergic to the components of this drug, patients with severe liver dysfunction, those with muscle disorders, patients taking certain immunosuppressants, individuals with severe renal impairment, and women who are pregnant or breastfeeding should not take this drug. Also, high-dose use is prohibited in patients at risk of muscle disorders. Risk factors include moderate renal impairment, hypothyroidism, family history of muscle disorders, and alcohol abuse. This drug contains lactose, so it should not be taken by patients with lactose intolerance or related genetic disorders. Patients with a history of liver disease or those who consume large amounts of alcohol should have liver function tests done before taking this drug and periodically during treatment. If symptoms such as muscle pain, muscle weakness, or myopathy appear, notify a doctor immediately and, if necessary, blood tests should be conducted to check for muscle damage. In particular, if muscle enzyme levels increase to more than five times the normal upper limit, the medication should be discontinued. Patients with acute severe conditions or serious metabolic diseases should temporarily stop taking this drug. Use should also be discontinued in case of severe myasthenia gravis or ocular myasthenia. Care should be taken when taking this drug with certain medications (e.g., fibrates, cyclosporine, some antibiotics, and antifungals) as the risk of muscle damage may increase. Renal function tests are necessary during high-dose use, and Asian patients may have higher systemic drug concentrations, which may require dose adjustments. Women who are pregnant or breastfeeding should not take this drug, and women with the potential for pregnancy should use appropriate contraception. In cases of overdose, there are no specific antidotes, so treatment should be based on symptoms with liver function and muscle enzyme tests conducted. Dizziness may occur while taking this medication, so caution is needed when driving or operating machinery. Lastly, this medicine can rarely cause serious skin reactions or liver dysfunction, neurological abnormalities, so any unusual symptoms should be reported to healthcare professionals immediately.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal bloating, abnormal liver function tests, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This drug must be stored in a tightly sealed container to avoid exposure to air or moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This way, the effectiveness of the medicine can be safely maintained for a long time.
Pink round film-coated tablet
30 tablets (10 tablets/PTP*3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.